CA19-9/Sialyl Lewisa (GI Tumor Marker) Antibody
Product Sizes
100 ug
£671.00
MSM1-25-P1BX-100UG
About this Product
- SKU:
- MSM1-25-P1BX
- Application:
- Immunohistochemistry
- translate.label.attr.clone:
- 121SLE
- Clonality:
- Monoclonal
- Extra Details:
- CA19-9; a carbohydrate epitope expressed on a high MW (400kDa) mucin glycoprotein; is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues; sialyl Lewisa antigen is present in ductal epithelium of the breast; kidney; salivary gland; and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas; including adenocarcinomas of the stomach; intestine; and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially; CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is excellent for staining of formalin-fixed; paraffin-embedded tissues.
- Host:
- Mouse
- Immunogen:
- Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B- patient (0Le).
- Isotype:
- IgM
- Molecular Weight:
- >400kDa
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
- Supplier:
- NeoBiotechnologies
- Type:
- Antibodies: Monoclonal Antibody
- Manufacturer's Data Sheet:https://www.neobiotechnologies.com/download-datasheet/?PID=125524
